2.1. Study Design
The present study represents a preliminary report of the results of the ongoing RADIOSA trial [Patients enrolled in the trial are randomized into two treatment arms:Arm A—MDT with stereotactic radiotherapy on all metastatic sites;Arm B—MDT with stereotactic radiotherapy on all metastatic sites + 6 months of ADT.The study (NCT03940235, AIRC IG-22159) [